Objectives To compare perioperative and short-term postoperative complication rates
between patients receiving radical cystectomy (RC) after neoadjuvant chemotherapy (NAC) …

Objective To determine whether use of neoadjuvant chemotherapy (NAC) is associated with
a higher risk of post-operative complications following radical cystectomy (RC) for bladder …

Purpose To evaluate patient-reported outcomes (PROs) for bladder cancer patients
undergoing neoadjuvant chemotherapy (NAC) prior to radical cystectomy (RC) using …

Background Neoadjuvant chemotherapy (NAC) is underutilized in the treatment of bladder
cancer (BC). Objective To investigate the effect of NAC on the risk of surgical complications …

Background Although therapeutic guidelines recommend the use of neoadjuvant
chemotherapy before radical cystectomy (RC) in patients who have muscle-invasive bladder …

Simple Summary Current guidelines recommend neoadjuvant chemotherapy (NAC) in
muscle invasive, urothelial carcinoma of the urinary bladder patients treated with radical …

Methods: We relied on the Surveillance, Epidemiology and End Results (SEER)-Medicare
database for non-metastatic, muscle-invasive (T2–T4a) urothelial carcinoma of the urinary …

Background The current guidelines do not recommend adjuvant chemotherapy (AC) for
patients with adverse pathologic findings after neoadjuvant chemotherapy (NAC) and …

Adding chemotherapy to radical cystectomy (RC) may improve outcome. Neoadjuvant
treatment is advocated by guidelines based on meta-analysis data but is severely …

Purpose Despite the increasing number of studies confirming the importance of neoadjuvant
chemotherapy (NC) in patients before radical cystectomy (RC) for bladder cancer (BCa), NC …